Deciphera Pharmaceuticals (DCPH) SEC Filings & 10K Form

$25.37
-0.01 (-0.04%)
(As of 05/6/2024 ET)

Recent Deciphera Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/30/2024
8:06 AM
Deciphera Pharmaceuticals (Subject)
ONO PHARMACEUTICAL CO., LTD. (Filed by)
Form SC TO-C
04/30/2024
5:08 AM
Deciphera Pharmaceuticals (Subject)
Form SC14D9C
04/29/2024
4:23 PM
Deciphera Pharmaceuticals (Subject)
Form SC14D9C
04/29/2024
4:24 PM
Deciphera Pharmaceuticals (Subject)
Form SC14D9C
04/29/2024
6:12 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:38 PM
Deciphera Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:43 PM
Deciphera Pharmaceuticals (Filer)
Form ARS
04/25/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
3:30 PM
Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form PRER14A
04/11/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form PRE 14A
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
4:32 PM
Deciphera Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/09/2024
3:30 PM
Brightstar Associates LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
3:30 PM
Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:52 AM
Deciphera Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2024
6:11 AM
Deciphera Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2024
3:52 PM
Deciphera Pharmaceuticals (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
02/06/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
8:45 AM
Deciphera Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:14 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:05 PM
Deciphera Pharmaceuticals (Subject)
Martin Daniel C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2023
6:06 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:11 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/05/2023
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Dhanak Dashyant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2023
6:06 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:09 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:05 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The best inflation-proof investment (Ad)

The markets are CRAZY right now. Which is why thousands of investors are flocking into one little-known company.

Click here for the full story
06/23/2023
3:05 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:06 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DCPH) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners